Intravenous pantoprazole utilization in a level 1 trauma center
- 21 August 2007
- journal article
- Published by Springer Nature in Surgical Endoscopy
- Vol. 22 (4) , 967-973
Abstract
In recent years there has been a rapid increase in the use of proton pump inhibitors. Our institution has recently had several shortages of IV pantoprazole, each lasting 7–10 days. The purpose of our study was to evaluate in-patient usage of IV pantoprazole. We hypothesized that hospitalized patients with upper gastrointestinal bleeding (GIB) or risk for stress ulcers inappropriately received IV pantoprazole based on current literature. This was a retrospective study of 165 consecutive in-patients identified as receiving pantoprazole from December 2004 to March 2005. Only patients receiving IV pantoprazole were included (n = 78). Data collected included demographics, indication and dosing of pantoprazole, admitting team (surgery vs. medicine), and risk factors for stress ulcers. Our study population had a mean age of 54 ± 17 years and 62% were male. Overall, 45% (35/78) of patients receiving IV pantoprazole had an appropriate indication, and 19% (15/78) received the correct dose. Of the 78 patients, 43 (55%) were treated with pantoprazole for stress ulcer prophylaxis (SUP), and 35 (45%) patients were treated for GIB. We found that none of the 43 patients treated for SUP had an appropriate indication for pantoprazole, but all of the patients with GIB (35) had an appropriate indication. Of the 35 patients treated for GIB with pantoprazole, only 40% (14/35) received the correct dose. In all cases of incorrect dosing, the patients were underdosed. Pantoprazole is not being prescribed appropriately for stress ulcer prophylaxis in our patient population. Even in patients appropriately receiving pantoprazole the majority were prescribed an incorrect dose. Appropriate indications and dosing of pantoprazole could eliminate the shortages seen at our institution.Keywords
This publication has 32 references indexed in Scilit:
- Review article: the use of gastric acid-inhibitory drugs-physiological and pathophysiological considerationsAlimentary Pharmacology & Therapeutics, 2007
- Predictors of inappropriate utilization of intravenous proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 2006
- Long‐term use of acid suppression started inappropriately during hospitalizationAlimentary Pharmacology & Therapeutics, 2005
- Systematic review: is there excessive use of proton pump inhibitors in gastro‐oesophageal reflux disease?Alimentary Pharmacology & Therapeutics, 2004
- Proton pump inhibitor treatment for acute peptic ulcer bleeding2004
- Prescription of Proton Pump Inhibitors Before Endoscopy: A Potential Cause of Missed Diagnosis of Early Gastric CancersArchives of Family Medicine, 2000
- Marked increase in gastric acid secretory capacity after omeprazole treatment.Gut, 1996
- Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazoleAlimentary Pharmacology & Therapeutics, 1996
- Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.Gut, 1994
- Potential Hazards of Long-Term Acid SuppressionScandinavian Journal of Gastroenterology, 1990